Examples
| Generic Name | Brand Name |
|---|
| conjugated estrogens/medroxyprogesterone | Premphase, Prempro |
| estradiol-norethindrone acetate | Activella, Femhrt |
| estradiol/norgestimate | Ortho-Prefest |
The combination of estrogen and progestin is commonly called
hormone replacement therapy (HRT). For information on estrogen replacement
therapy (estrogen without progestin), see
estrogen for osteoporosis.
How It Works
Taking
estrogen brings a woman's estrogen levels back to
premenopausal levels. This slows bone thinning and causes some increase in bone
thickness. Progestin works like the naturally occurring hormone
progesterone and prevents
endometrial cancer from developing in women who have a
uterus.
The
Women's Health Initiative (WHI) study showed that
hormone replacement therapy (HRT) can lower the risk
of osteoporosis-related hip fractures and other fractures in postmenopausal
women.1 But taking HRT led to small increases in the
number of women who developed
breast cancer,
ovarian cancer,
heart attack,
stroke, blood clots (pulmonary
embolism and
deep vein thrombosis), and
Alzheimer's disease and other
dementias. Most experts recommend that HRT should only
be considered for women with a significant risk of osteoporosis that outweighs
the risks of taking HRT.2, 3 To
read more about this study, see
WHI:
Risks and benefits of taking HRT.
While hormone therapy is typically not recommended as the first
choice for osteoporosis, if you are at high risk for osteoporosis and cannot
take other medications, your doctor may recommend HRT. You may need to take HRT
if you continue to have bone loss while taking bisphosphonate medication, such
as risedronate (Actonel) or alendronate (Fosamax). In this case, you may need
to take both the bisphosphonate medication and HRT. Studies show that taking a
bisphosphonate with hormone therapy results in increased bone mass when
compared to taking either a bisphosphonate or hormone therapy alone.4, 5
Researchers are studying the effects of low-dose estrogen on women
age 65 and older. An early, small study indicates that a low estrogen dose
(one-quarter that of conventional ERT) may provide the same benefit—increased
bone density and decreased fractures—as the higher dose. In the same study,
about one-third of the women were given the low estrogen dose and progesterone
(because these women did not have hysterectomies). This group of women also
experienced increased bone density. However, the long-term risks of taking
low-dose estrogen (and progesterone in one-third of the cases) were not studied
and are unclear.6, 7
Why It Is Used
Estrogen and progestin help prevent
osteoporosis from developing in postmenopausal
women.
How Well It Works
A Women's Health Initiative (WHI) study showed that hormone
replacement therapy (HRT) can reduce the risk for osteoporosis-related hip
fractures and other fractures in postmenopausal women.1
Side Effects
Common side effects include:
- Breast
tenderness.
- Headache.
- Postmenopausal bleeding.
See Drug Reference for a full list of side effects. (Drug Reference
is not available in all systems).
What To Think About
You should not take HRT if you have been diagnosed with any of the
following conditions:
- Pregnancy
- Uterine
cancer
- Breast cancer
- Ovarian cancer
- History
of or active deep vein thrombosis
- Unexplained vaginal
bleeding
- Liver disease
- Stroke
Complete the
new medication information form (PDF)
(What is a PDF document?)
to help you understand this medication.